Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (33)
Etienne Masle-Farquhar, Timothy J. Peters, Lisa A. Miosge, Ian A. Parish, Christoph Weigel, Christopher C. Oakes, Joanne H. Reed & Christopher C. Goodnow. (2022) Uncontrolled CD21low age-associated and B1 B cell accumulation caused by failure of an EGR2/3 tolerance checkpoint. Cell Reports 38:3, pages 110259.
Crossref
Crossref
C. I. Edvard Smith & Jan A. Burger. (2021) Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling Pathway. Frontiers in Immunology 12.
Crossref
Crossref
Ilenia Sana, Maria Elena Mantione, Piera Angelillo & Marta Muzio. (2021) Role of NFAT in Chronic Lymphocytic Leukemia and Other B-Cell Malignancies. Frontiers in Oncology 11.
Crossref
Crossref
Hamza A. Alaswad, Amani A. Mahbub, Christine L. Le Maitre & Nicola Jordan-Mahy. (2021) Molecular Action of Polyphenols in Leukaemia and Their Therapeutic Potential. International Journal of Molecular Sciences 22:6, pages 3085.
Crossref
Crossref
Farrukh T. Awan & John C. Byrd. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
1850
1871.e5
.
Caspar da Cunha-Bang & Carsten Utoft Niemann. (2018) Targeting Bruton’s Tyrosine Kinase Across B-Cell Malignancies. Drugs 78:16, pages 1653-1663.
Crossref
Crossref
Uri Rozovski, David M. Harris, Ping Li, Zhiming Liu, Preetesh Jain, Alessandra Ferrajoli, Jan Burger, Phillip Thompson, Nitin Jain, William Wierda, Michael J. Keating & Zeev Estrov. (2018) STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cells. Oncotarget 9:72, pages 33710-33718.
Crossref
Crossref
M Hahn, J-P Bürckert, C A Luttenberger, S Klebow, M Hess, M Al-Maarri, M Vogt, S Reißig, M Hallek, A Wienecke-Baldacchino, T Buch, C P Muller, C P Pallasch, F T Wunderlich, A Waisman & N Hövelmeyer. (2017) Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling. Leukemia 32:1, pages 72-82.
Crossref
Crossref
Y Pekarsky & C M Croce. (2014) Role of miR-15/16 in CLL. Cell Death & Differentiation 22:1, pages 6-11.
Crossref
Crossref
John C. Byrd & Joseph M. Flynn. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
1958
1978.e7
.
Veronica Balatti, Yuri Pekarsky, Lara Rizzotto & Carlo M. Croce. 2013. MicroRNAs in Medicine. MicroRNAs in Medicine
383
401
.
Amit K. Mittal, Nagendra K. Chaturvedi, Rae A. Rohlfsen, Payal Gupta, Avadhut D. Joshi, Ganapati V. Hegde, R. Gregory Bociek & Shantaram S. Joshi. (2013) Role of CTLA4 in the Proliferation and Survival of Chronic Lymphocytic Leukemia. PLoS ONE 8:8, pages e70352.
Crossref
Crossref
Veronica Balatti, Yuri Pekarky, Lara Rizzotto & Carlo M. Croce. 2013. Advances in Chronic Lymphocytic Leukemia. Advances in Chronic Lymphocytic Leukemia
309
325
.
Christine Le RoyPierre-Antoine Deglesne, Nathalie Chevallier, Taoufik Beitar, Virginie Eclache, Maude QuettierMarouane Boubaya, Rémi Letestu, Vincent Lévy, Florence Ajchenbaum-Cymbalista & Nadine Varin-Blank. (2012) The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia. Blood 120:2, pages 356-365.
Crossref
Crossref
L. Kardava, Q. Yang, A. St. Leger, K. A. Foon, S. Lentzsch, A. N. Vallejo, C. Milcarek & L. Borghesi. (2011) The B lineage transcription factor E2A regulates apoptosis in chronic lymphocytic leukemia (CLL) cells. International Immunology 23:6, pages 375-384.
Crossref
Crossref
Soizic Garaud, Ahsen Morva, Sébastien Lemoine, Sophie Hillion, Anne Bordron, Jacques-Olivier Pers, Christian Berthou, Rizgar A. Mageed, Yves Renaudineau & Pierre Youinou. (2011) CD5 Promotes IL-10 Production in Chronic Lymphocytic Leukemia B Cells through STAT3 and NFAT2 Activation. The Journal of Immunology 186:8, pages 4835-4844.
Crossref
Crossref
Zhiming Liu, Inbal Hazan-Halevy, David M. Harris, Ping Li, Alessandra Ferrajoli, Stefan Faderl, Michael J. Keating & Zeev Estrov. (2011) STAT-3 Activates NF-κB in Chronic Lymphocytic Leukemia Cells. Molecular Cancer Research 9:4, pages 507-515.
Crossref
Crossref
Shuqiang Li, Howell F. Moffett, Jun Lu, Lillian Werner, Hao Zhang, Jerome Ritz, Donna Neuberg, Kai W. Wucherpfennig, Jennifer R. Brown & Carl D. Novina. (2011) MicroRNA Expression Profiling Identifies Activated B Cell Status in Chronic Lymphocytic Leukemia Cells. PLoS ONE 6:3, pages e16956.
Crossref
Crossref
Yuri Pekarsky, Nicola Zanesi & Carlo M. Croce. (2010) Molecular basis of CLL. Seminars in Cancer Biology 20:6, pages 370-376.
Crossref
Crossref
Alexey Palamarchuk, Alexey Efanov, Natalya Nazaryan, Urmila Santanam, Hansjuerg Alder, Laura Rassenti, Thomas Kipps, Carlo M. Croce & Yuri Pekarsky. (2010) 13q14 deletions in CLL involve cooperating tumor suppressors. Blood 115:19, pages 3916-3922.
Crossref
Crossref
M.T.S. Bertilaccio, C. Scielzo, M. Muzio & F. Caligaris-Cappio. (2010) An overview of chronic lymphocytic leukaemia biology. Best Practice & Research Clinical Haematology 23:1, pages 21-32.
Crossref
Crossref
Marta Muzio & Federico Caligaris-Cappio. 2008. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia
45
67
.
Marta Muzio, Benedetta Apollonio, Cristina Scielzo, Michela Frenquelli, Irene Vandoni, Vassiliki Boussiotis, Federico Caligaris-Cappio & Paolo Ghia. (2008) Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. Blood 112:1, pages 188-195.
Crossref
Crossref
M Duechler, M Shehata, J D Schwarzmeier, A Hoelbl, M Hilgarth & R Hubmann. (2004) Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2. Leukemia 19:2, pages 260-267.
Crossref
Crossref
George B Segel, Timothy J Woodlock, Jia Xu, Liqiong Li, Raymond E Felgar, Daniel H Ryan, Marshall A Lichtman & Nancy Wang. (2003) Early gene activation in chronic leukemic B lymphocytes induced toward a plasma cell phenotype. Blood Cells, Molecules, and Diseases 30:3, pages 277-287.
Crossref
Crossref
Nicholas ChiorazziManlio Ferrarini. (2003) B Cell Chronic Lymphocytic Leukemia: Lessons Learned from Studies of the B Cell Antigen Receptor. Annual Review of Immunology 21:1, pages 841-894.
Crossref
Crossref
A. L. Shaffer, Andreas Rosenwald & Louis M. Staudt. (2002) Lymphoid Malignancies: the dark side of B-cell differentiation. Nature Reviews Immunology 2:12, pages 920-933.
Crossref
Crossref
Anne J. NovakRichard J. BramNeil E. KayDiane F. Jelinek. (2002) Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood 100:8, pages 2973-2979.
Crossref
Crossref
Christian Kneitz, Martin Goller, Hans-Peter Tony, Andreas Simon, Corinne Stibbe, Thomas König, Edgar Serfling & Andris Avots. (2002) The CD23b promoter is a target for NF-AT transcription factors in B-CLL cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1588:1, pages 41-47.
Crossref
Crossref
Jacek M. WitkowskiEmilia Zmuda-TrzebiatowskaJakub M. SwierczMiroslawa CichorekHanna CiepluchKrzysztof LewandowskiEwa BrylAndrzej Hellmann. (2002) Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells. Blood 100:5, pages 1802-1809.
Crossref
Crossref
Siew-Cheng Wong, Weng-Keong Chew, Joy En-Lin Tan, Alirio J. Melendez, Florence Francis & Kong-Peng Lam. (2002) Peritoneal CD5+ B-1 Cells Have Signaling Properties Similar to Tolerant B Cells. Journal of Biological Chemistry 277:34, pages 30707-30715.
Crossref
Crossref
C. Kneitz, M. Goller, R. Seggewiss, A. Yaman, E. Serfling & H.P. Tony. (2000) STAT6 and the regulation of CD23 expression in B-chronic lymphocytic leukemia. Leukemia Research 24:4, pages 331-337.
Crossref
Crossref
R. Berland & H. H. Wortis. 2000. B1 Lymphocytes in B Cell Neoplasia. B1 Lymphocytes in B Cell Neoplasia
131
140
.